BioVie Inc. Announces Pricing of Public Offering
The gross proceeds to the Company from the offering are expected to be approximately $21 million, before deducting placement agent fees and offering expenses.
- The gross proceeds to the Company from the offering are expected to be approximately $21 million, before deducting placement agent fees and offering expenses.
- The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.
- The offering is expected to close on March 6, 2024, subject to satisfaction of customary closing conditions.
- The offering will be made only by means of a written prospectus.